Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-008831

Director acquired 29,528 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SARIN RAVI YANG Director 2023-03-17 Grant or award +29,528 75,427 D
Loading xslF345X04/wf-form4_167944632508935.xml…